Publications
395
Citations
20,127
Est. group size
~2
Recurring co-author estimate
Active years
48
Publishing since 1979
Typically publishes in teams of ~13 · 13% small-team papers (≤3 authors) · across 40 venues
- Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines
Transplantation and Cellular Therapy · 2026
- Differential Effects of GVHD Therapies on Intestinal Epithelium
Transplantation and Cellular Therapy · 2026
- Impact of Grade 2 and 3 Infections on Allogeneic Hematopoietic Cell Transplant Outcomes. a Validation Study of BMT CTN Infection Grading System (BMT CTN IGS)
Transplantation and Cellular Therapy · 2026
- High Molecular Weight Isoforms of Thymic Stromal Lymphopoietin Correlate with Presence and Severity of Acute Graft Versus Host Disease
Transplantation and Cellular Therapy · 2026
- Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Blood Immunology & Cellular Therapy · 2026
- Long‐term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial
UNC Libraries · 2026
- Tisagenlecleucel (tisa-cel) in pediatric and young adult patients with high-risk (HR) B-cell acute lymphoblastic leukemia (B-ALL) and minimal residual disease (MRD) at the end of frontline consolidation (EOC).
Journal of Clinical Oncology · 2026
- ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202
Research Square · 2026
- Prediction and Prognostication of Acute Graft‐Versus‐Host Disease by <scp>MAGIC</scp> Biomarkers
American Journal of Hematology · 2025
- Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD
Blood · 2025
- Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease
Gut · 2025
- Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation
Blood Advances · 2025
- Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome
EBioMedicine · 2025
- Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity
Transplantation and Cellular Therapy · 2025
- Evaluating thymic stromal lymphopoietin (TSLP) as a biomarker in acute graft versus host disease
Blood · 2025
- Blood×41
- Transplantation and Cellular Therapy×29
- Biology of Blood and Marrow Transplantation×19
- Blood Advances×18
- Bone Marrow Transplantation×7
- Andrew C. Harris
Medicine · University of Michigan
- John Magenau
Medicine · University of Michigan
- Hannah Choe
Medicine · The Ohio State University
- Marcos de Lima
Medicine · The Ohio State University
- Tracey Churay
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile